TTrialPathMatch Me to Trials
← Back to trials
RecruitingAtopic Dermatitis

A Study Evaluating TRIV-573 in Atopic Dermatitis

Eligible age

18–75 yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo). The study duration for individual participants is up to 40 weeks, including a Screening period of up to 30 days.

Sponsor: Triveni Bio

You may qualify if…

  • ✓ Has Atopic Dermatitis.
  • ✓ Has moderate to severe, active and symptomatic atopic dermatitis.

You may not qualify if…

  • ✕ Severe or uncontrolled medical conditions.
  • ✕ Use of prohibited medications within stated washout periods.

Where it's recruiting

California

Fountain Valley · Los Angeles

Florida

Boca Raton · Miami

Indiana

Indianapolis

Michigan

Bay City

Ohio

Boardman

Pennsylvania

Camp Hill

South Carolina

Myrtle Beach

Texas

San Antonio

Washington

Spokane

Source: ClinicalTrials.gov · NCT07782333 · last updated 2026-10-28

A Study Evaluating TRIV-573 in Atopic Dermatitis · TrialPath